Ignite Creation Date:
2024-05-06 @ 11:03 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03420222
Status:
TERMINATED
Last Update Posted:
2022-05-24
First Post:
2018-01-19
Brief Title:
Study to Assess the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-18
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-19
First Submit QC Date:
January 28 2018
Study First Post Date:
2018-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-05-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2019-12-20
Disp First Submit QC Date:
April 29 2022
Disp First Post Date:
2022-05-24
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-04-29
Last Update Post Date:
2022-05-24
Last Update Post Date Type:
ACTUAL